Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$214,778
-$22,151 QoQ
Shares Held
1,700
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1,885
of 2,266 holders
Holding Since
Dec 2022
4 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First Bancorp, Inc /ME/ holds $5,656,881 across 11 Drug Manufacturers - General names. GILD ranks #8 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
8,272 | $2,100,838 | |
| 2 | ABBV |
AbbVie Inc.
|
3,278 | $824,875 | |
| 3 | MRK |
Merck & Co., Inc.
|
5,509 | $707,906 | |
| 4 | PFE |
Pfizer Inc
|
20,600 | $496,047 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
7,257 | $418,147 | |
| 6 | LLY |
ELI LILLY & Co
|
290 | $347,834 | |
| 7 | AMGN |
Amgen Inc
|
720 | $260,726 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
1,700 | $214,778 |
All Filings in GILD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $214,778 | 1,700 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $236,929 | 1,700 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $208,658 | 1,700 | Shares | Sole | 2026-01-26 | |
| 2022-12-31 | $211,191 | 2,460 | Shares | Sole | 2023-02-01 | |
| No filing history on record for this holder in this stock. | ||||||